This device is commercially available for use in select international markets.
Expand Your Reach. Treat More Patients With Better Results.
Now you can treat patients with focal chronic intractable pain that you could not effectively treat before with the Axium™ Neurostimulator System—the only system specifically designed to stimulate the dorsal root ganglion (DRG), which has been clinically validated to provide superior relief over conventional tonic spinal cord stimulation (SCS).*
DRG therapy expands the range of neurostimulation options you can offer and sets a new standard of care that may help you significantly improve patients’ lives.
DRG stimulation: A clinically proven therapy
DRG stimulation’s effectiveness has been proven in many international studies along with the U.S. ACCURATE study, the largest randomized neurostimulation clinical trial that compares conventional tonic SCS with DRG stimulation to treat chronic intractable CRPS of the lower limbs and peripheral causalgia. The findings demonstrate DRG stimulation enhances your ability to:
- Deliver superior pain relief:* The ACCURATE study showed that DRG stimulation is clinically superior to conventional tonic SCS in treating lower extremity pain (i.e., foot, knee, hip and groin) associated with focal chronic intractable pain. The stimulation of the DRG allows for the ability to precisely stimulate specific regions of the dermatome that is otherwise difficult to individually target with broadly applied traditional SCS.
- Treat more patients: DRG stimulation provides a therapy option for patients with focal chronic intractable pain conditions such as CRPS of the hand and foot, groin pain, peripheral neuropathic and phantom limb pain.2
- Provide stable pain relief: Studies have shown that DRG stimulation provides stable, long-term pain relief for at least 12 months.4
See more clinical evidence.
Expanding the treatable patient population
The Axium™ Neurostimulator System is part of our dorsal root ganglion therapy portfolio. Our vision is to transform the management of chronic pain by expanding the range of neurostimulation options available and setting a new standard of care to help improve the lives of more patients. Read more about the portfolio and our approach to chronic pain management.